Leukemia Drug Iclusig: Deaths and Serious Injury
The leukemia drug Icusig that was given rapid approval by the FDA in December 2012 is now off the market and clinical trials are halted. The FDA received an alarming number of reports of more than a dozen deaths and a still-to-be-counted tally of serious injury from blood clots, heart attack, stroke, lack of blood… Continue reading